The activity of ofloxacin against methicillin-resistant staphylococcus aureus
Само за регистроване кориснике
1986
Чланак у часопису (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
The return of multiresistant Staphylococcus aureus strains and the appearance of methicillin-resistant strains resistant as well to rifampin and fusidic acid increase the need for new agents to treat infections caused by such strains. Ofloxacin susceptibility of 109 selected methicillin-resistant staphylococci (with MIC90 of 1,000 mg/l for methicillin, 1.3% being resistant to gentamicin with MICs ranging from 25 to 100 mg/l, chloramphenicol MICs ranging from 25 to 100 mg/l and resistant to β-lactam-antibiotics and clindamycin), was determined by an agar dilution method. MICs of ofloxacin for methicillin-resistant staphylococci ranged from 0.09 to 0.78 mg/l, with an MIC90 of 0.39 mg/l. The in vitro results suggest a possible clinical role for ofloxacin in infections caused by methicillin-resistant staphylococci. However, further investigations are needed.
Извор:
Infection, 1986, 14, 4 Supplement, S231-S232Издавач:
- Springer-Verlag
DOI: 10.1007/BF01661278
ISSN: 0300-8126
PubMed: 3469151
Scopus: 2-s2.0-0022845799
Институција/група
TorlakTY - JOUR AU - Mraović, Mirjana AU - Čanić-Radojlović, M. PY - 1986 UR - http://intor.torlakinstitut.com/handle/123456789/30 AB - The return of multiresistant Staphylococcus aureus strains and the appearance of methicillin-resistant strains resistant as well to rifampin and fusidic acid increase the need for new agents to treat infections caused by such strains. Ofloxacin susceptibility of 109 selected methicillin-resistant staphylococci (with MIC90 of 1,000 mg/l for methicillin, 1.3% being resistant to gentamicin with MICs ranging from 25 to 100 mg/l, chloramphenicol MICs ranging from 25 to 100 mg/l and resistant to β-lactam-antibiotics and clindamycin), was determined by an agar dilution method. MICs of ofloxacin for methicillin-resistant staphylococci ranged from 0.09 to 0.78 mg/l, with an MIC90 of 0.39 mg/l. The in vitro results suggest a possible clinical role for ofloxacin in infections caused by methicillin-resistant staphylococci. However, further investigations are needed. PB - Springer-Verlag T2 - Infection T1 - The activity of ofloxacin against methicillin-resistant staphylococcus aureus EP - S232 IS - 4 Supplement SP - S231 VL - 14 DO - 10.1007/BF01661278 ER -
@article{ author = "Mraović, Mirjana and Čanić-Radojlović, M.", year = "1986", abstract = "The return of multiresistant Staphylococcus aureus strains and the appearance of methicillin-resistant strains resistant as well to rifampin and fusidic acid increase the need for new agents to treat infections caused by such strains. Ofloxacin susceptibility of 109 selected methicillin-resistant staphylococci (with MIC90 of 1,000 mg/l for methicillin, 1.3% being resistant to gentamicin with MICs ranging from 25 to 100 mg/l, chloramphenicol MICs ranging from 25 to 100 mg/l and resistant to β-lactam-antibiotics and clindamycin), was determined by an agar dilution method. MICs of ofloxacin for methicillin-resistant staphylococci ranged from 0.09 to 0.78 mg/l, with an MIC90 of 0.39 mg/l. The in vitro results suggest a possible clinical role for ofloxacin in infections caused by methicillin-resistant staphylococci. However, further investigations are needed.", publisher = "Springer-Verlag", journal = "Infection", title = "The activity of ofloxacin against methicillin-resistant staphylococcus aureus", pages = "S232-S231", number = "4 Supplement", volume = "14", doi = "10.1007/BF01661278" }
Mraović, M.,& Čanić-Radojlović, M.. (1986). The activity of ofloxacin against methicillin-resistant staphylococcus aureus. in Infection Springer-Verlag., 14(4 Supplement), S231-S232. https://doi.org/10.1007/BF01661278
Mraović M, Čanić-Radojlović M. The activity of ofloxacin against methicillin-resistant staphylococcus aureus. in Infection. 1986;14(4 Supplement):S231-S232. doi:10.1007/BF01661278 .
Mraović, Mirjana, Čanić-Radojlović, M., "The activity of ofloxacin against methicillin-resistant staphylococcus aureus" in Infection, 14, no. 4 Supplement (1986):S231-S232, https://doi.org/10.1007/BF01661278 . .